GBIO insider transactions
Generation Bio Co. (GBIO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for GBIO
- SEC Form 4 filed by Large owner Atlas Venture Fund X, L.P.4 - Generation Bio Co. (0001733294) (Issuer)
- Director Stehman-Breen Catherine closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Rhodes Jason P4 - Generation Bio Co. (0001733294) (Issuer)
- Director Rowland Charles A Jr closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Quinn Anthony G. closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Nicholson Donald William closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Mcdonough Geoff closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Jonas Jeffrey M4 - Generation Bio Co. (0001733294) (Issuer)
- INTERIM CEO AND PRESIDENT Howze Yalonda closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF FINANCIAL OFFICER Conway Kevin John closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Cooper Ronald Harold Wilfred closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Christensen Gustav closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Appelhans Dannielle closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Chief Financial Officer Conway Kevin John converted options into 235 shares and covered exercise/tax liability with 72 shares, increasing direct ownership by 9% to 2,072 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Mcdonough Geoff covered exercise/tax liability with 550 shares and converted options into 1,582 shares, increasing direct ownership by 0.75% to 138,492 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INTERIM CEO & PRESIDENT Howze Yalonda converted options into 1,673 shares and covered exercise/tax liability with 495 shares, increasing direct ownership by 46% to 3,759 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Chief Financial Officer Conway Kevin John converted options into 59 shares and covered exercise/tax liability with 17 shares, increasing direct ownership by 2% to 1,909 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Mcdonough Geoff converted options into 395 shares and covered exercise/tax liability with 137 shares, increasing direct ownership by 0.19% to 137,460 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF LEGAL OFFICER Howze Yalonda converted options into 335 shares and covered exercise/tax liability with 99 shares, increasing direct ownership by 10% to 2,581 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Director Mcdonough Geoff converted options into 659 shares and covered exercise/tax liability with 293 shares, increasing direct ownership by 0.27% to 137,202 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Samayoa Phillip4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF OPERATING OFFICER Paone Antoinette4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF OPERATING OFFICER Paone Antoinette converted options into 159 shares and covered exercise/tax liability with 47 shares, increasing direct ownership by 3% to 3,658 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF SCIENTIFIC OFFICER Samayoa Phillip covered exercise/tax liability with 34 shares and converted options into 114 shares, increasing direct ownership by 0.57% to 14,138 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- PRESIDENT AND CEO Mcdonough Geoff converted options into 527 shares and covered exercise/tax liability with 155 shares, increasing direct ownership by 0.27% to 136,836 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Chief Financial Officer Conway Kevin John converted options into 58 shares and covered exercise/tax liability with 18 shares, increasing direct ownership by 2% to 1,867 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF LEGAL OFFICER Howze Yalonda converted options into 334 shares and covered exercise/tax liability with 99 shares, increasing direct ownership by 11% to 2,345 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF OPERATING OFFICER Paone Antoinette covered exercise/tax liability with 468 shares and converted options into 1,592 shares, increasing direct ownership by 3% to 35,465 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF LEGAL OFFICER Howze Yalonda converted options into 3,347 shares and covered exercise/tax liability with 983 shares, increasing direct ownership by 13% to 21,101 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Chief Financial Officer Conway Kevin John converted options into 587 shares and covered exercise/tax liability with 173 shares, increasing direct ownership by 2% to 18,273 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- PRESIDENT AND CEO Mcdonough Geoff converted options into 5,273 shares and covered exercise/tax liability with 1,548 shares, increasing direct ownership by 0.27% to 1,364,648 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF SCIENTIFIC OFFICER Samayoa Phillip converted options into 1,147 shares and covered exercise/tax liability with 337 shares, increasing direct ownership by 0.58% to 140,588 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Cooper Ronald Harold Wilfred4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Christensen Gustav4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Quinn Anthony G.4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Stehman-Breen Catherine4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Nicholson Donald William4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Rowland Charles A Jr4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Jonas Jeffrey M4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Rhodes Jason P4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Director Appelhans Dannielle4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF SCIENTIFIC OFFICER Samayoa Phillip converted options into 1,147 shares and covered exercise/tax liability with 337 shares, increasing direct ownership by 0.63% to 128,519 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- PRESIDENT AND CEO Mcdonough Geoff covered exercise/tax liability with 1,548 shares and converted options into 5,274 shares, increasing direct ownership by 0.28% to 1,349,664 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF OPERATING OFFICER Paone Antoinette converted options into 1,592 shares and covered exercise/tax liability with 468 shares, increasing direct ownership by 5% to 23,082 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF LEGAL OFFICER Howze Yalonda converted options into 3,347 shares and covered exercise/tax liability with 983 shares, increasing direct ownership by 14% to 18,737 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Chief Financial Officer Conway Kevin John converted options into 587 shares and covered exercise/tax liability with 173 shares, increasing direct ownership by 2% to 17,859 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- Chief Financial Officer Conway Kevin John converted options into 587 shares and covered exercise/tax liability with 204 shares, increasing direct ownership by 2% to 17,445 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF SCIENTIFIC OFFICER Samayoa Phillip converted options into 1,147 shares and covered exercise/tax liability with 398 shares, increasing direct ownership by 0.59% to 127,709 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF LEGAL OFFICER Howze Yalonda converted options into 3,347 shares and covered exercise/tax liability with 1,160 shares, increasing direct ownership by 15% to 16,373 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- PRESIDENT AND CEO Mcdonough Geoff covered exercise/tax liability with 1,828 shares and converted options into 5,274 shares, increasing direct ownership by 0.26% to 1,345,938 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- CHIEF OPERATING OFFICER Paone Antoinette converted options into 1,592 shares and covered exercise/tax liability with 552 shares, increasing direct ownership by 5% to 21,958 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Conway Kevin John4 - Generation Bio Co. (0001733294) (Issuer)
- New insider Conway Kevin John claimed ownership of 17,062 shares (SEC Form 3)3 - Generation Bio Co. (0001733294) (Issuer)
- Director Quinn Anthony G. bought $203,209 worth of shares (210,791 units at $0.96), increasing direct ownership by 238% to 299,286 units (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Samayoa Phillip4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF OPERATING OFFICER Paone Antoinette4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Mcdonough Geoff4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF LEGAL OFFICER Howze Yalonda4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Stanton Matthew4 - Generation Bio Co. (0001733294) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Norkunas Matthew4 - Generation Bio Co. (0001733294) (Issuer)